The numbers of patients who required permanent drug withdrawal due to neutropenia, ALT increase, AST increase and QTcF prolongation were 4 (0.8%), 29 (5.5%), 25 (4.8%) and 0, respectively. This evidence concerns the gene GPT and neutropenia.